Search Results

4-Hydroxytamoxifen 50mg  | 98.32%

APEXBIO TECHNOLOGY LLC

estrogen receptor modulator Endocrinology and Hormones|Estrogen/progestogen Receptor

More Information Supplier Page

×

4-Hydroxytamoxifen

4-Hydroxytamoxifen 10mg  | 98.32%

APEXBIO TECHNOLOGY LLC

estrogen receptor modulator Endocrinology and Hormones|Estrogen/progestogen Receptor

More Information Supplier Page

×

4-Hydroxytamoxifen

MI-136 25mg  | 98%

APEXBIO TECHNOLOGY LLC

menin-MLL interaction inhibitor Others|Menin-MLL

More Information Supplier Page

×

MI-136

MI-136 10mg  | 98%

APEXBIO TECHNOLOGY LLC

menin-MLL interaction inhibitor Others|Menin-MLL

More Information Supplier Page

×

MI-136

MI-136 5mg  | 98%

APEXBIO TECHNOLOGY LLC

menin-MLL interaction inhibitor Others|Menin-MLL

More Information Supplier Page

×

MI-136

A-1331852 100mg  | 98.1%

APEXBIO TECHNOLOGY LLC

BCL-XL inhibitor, potent and selective Apoptosis|Bcl-xL

More Information Supplier Page

×

A-1331852

FRAX486 5mg  | 99.7%

APEXBIO TECHNOLOGY LLC

p21-activated kinase (PAK) inhibitor Cell Cycle/Checkpoint|PAK1

More Information Supplier Page

×

FRAX486

FRAX486 10mg  | 99.7%

APEXBIO TECHNOLOGY LLC

p21-activated kinase (PAK) inhibitor Cell Cycle/Checkpoint|PAK1

More Information Supplier Page

×

FRAX486

FRAX486 50mg  | 99.7%

APEXBIO TECHNOLOGY LLC

p21-activated kinase (PAK) inhibitor Cell Cycle/Checkpoint|PAK1

More Information Supplier Page

×

FRAX486

FRAX486 100mg  | 99.7%

APEXBIO TECHNOLOGY LLC

p21-activated kinase (PAK) inhibitor Cell Cycle/Checkpoint|PAK1

More Information Supplier Page

×

FRAX486